Related by context. All words. (Click for frequent words.) 69 mortality morbidity 67 morbidity 65 atherothrombotic 65 Erythropoietic therapies may 64 maternal morbidity 64 venous thromboembolic disease 64 Exacerbations 64 postoperative morbidity 64 HIV HCV coinfected 64 perioperative mortality 64 atherothrombotic disease 63 persistency mortality 63 medication nonadherence 63 postoperative mortality 63 symptomatic intracranial 63 LV dysfunction 63 perioperative morbidity 63 HF hospitalization 63 recurrent ischemia 63 intravascular hemolysis 63 pulmonary exacerbations 63 hemorrhagic complications 63 postoperative AF 62 comorbid conditions 62 underdiagnosis 62 thrombotic complications 62 Hip fracture 62 macrovascular events 62 neurologic complications 62 morphometric vertebral fractures 62 coronary revascularization procedures 62 CVD mortality 61 HeFH 61 cardiovascular morbidity 61 neonatal morbidity 61 perioperative complications 61 potentially modifiable 61 antioxidant supplementation 61 diabetic microvascular complications 61 postoperative infections 61 Vitamin D insufficiency 61 cirrhosis liver failure 61 atherothrombosis 61 patients undergoing CABG 61 deep venous thromboses 61 anastomotic leak 61 perinatal morbidity 61 postoperative complications 61 upper gastrointestinal bleeding 61 symptomatic VTE 61 de ath 60 psychiatric comorbidity 60 Venous thromboembolism 60 cirrhotic patients 60 inpatient hospitalizations 60 Diabetic nephropathy 60 hemodynamically stable 60 parkinsonian symptoms 60 antithrombotic therapy 60 periprocedural MI 60 hyperglycaemia 60 Calcium intake 60 recurrent venous thromboembolism 60 thromboembolic complications 60 pulmonary capillary wedge 60 immunosuppression therapy 60 cardiopulmonary diseases 60 cardiovascular hospitalization 60 cardiovascular hospitalizations 60 bowel resection 60 hyperphenylalaninemia HPA due 60 postoperative atrial fibrillation 60 clinically heterogeneous 60 EGFR mutation status 60 coagulation abnormalities 60 HRQoL 60 hepatocellular carcinoma liver 60 coinfection 60 reinfarction 60 DVT PE 60 pharmacologic intervention 60 glycemic variability 60 thromboprophylaxis 60 IPAH 60 Genetic predisposition 59 coagulopathy 59 liver histology 59 extrapyramidal symptoms 59 serum aminotransferase levels 59 elevated triglyceride levels 59 osteoporotic fractures 59 severe asthma exacerbations 59 HbA1C levels 59 neurologic sequelae 59 chronicity 59 diabetic retinopathy DR 59 postoperative pulmonary 59 Myocardial infarction 59 recurrent myocardial infarction 59 comorbid illnesses 59 cytomegalovirus infection 59 nonadherence 59 CRBSI 59 Multivariate analysis revealed 59 echocardiographic parameters 59 atrophic gastritis 59 autonomic dysfunction 59 HRQL 59 AA Amyloidosis 59 atherogenic dyslipidemia 59 dyslipidaemia 59 cardiovascular mortality 59 microvascular disease 59 chronic thromboembolic pulmonary 59 NATRECOR ® 59 chronic hemodialysis 59 opioid analgesia 59 nonalcoholic steatohepatitis 59 bioprosthetic valve 59 psychosocial functioning 59 hemodialysis patients 59 COPD exacerbations 59 myocardial ischaemia 59 CP CPPS 58 microvascular complications 58 BSIs 58 chronic periodontitis 58 Sociodemographic 58 neurologic dysfunction 58 hyperbilirubinemia 58 Uncontrolled hypertension 58 ADHF 58 intracranial hemorrhage ICH 58 strong CYP#A# inducers 58 variceal bleeding 58 candidemia 58 nephrotoxicity 58 cardiovascular disease hypertension 58 predisposing factor 58 lumbar disk herniation 58 macrovascular complications 58 thromboembolic disease 58 pulmonary resection 58 ICD therapy 58 nonvertebral fracture 58 cerebral ischemia 58 rebleeding 58 oncologic outcomes 58 oral FTY# 58 β blockers 58 Renal dysfunction 58 elevated IOP 58 Non Alcoholic Fatty 58 nonfatal MI 58 Vertebral fractures 58 serum PTH 58 binary restenosis 58 NSAID induced GI 58 intra abdominal abscess 58 Thal Dex 58 secondary efficacy endpoint 58 epoetin therapy 58 CHD mortality 58 Cognitive impairment 58 neurodevelopmental outcomes 58 prostate cancer CaP 58 Chlamydia trachomatis infection 58 T2DM 58 periprocedural 58 psychiatric morbidity 58 impaired cognition 58 neutropenia dehydration dyspnea 58 psychiatric comorbidities 58 demonstrated clinically meaningful 58 causative pathogen 58 serum phosphate 58 invasive aspergillosis 58 polyp recurrence 58 angiographic outcomes 58 depressive symptomatology 58 myocardial reperfusion 58 morbidities 58 invasive candidiasis 58 subtrochanteric 58 clinically meaningful reductions 58 cardiometabolic risk 58 postoperative delirium 58 arterial revascularization 58 pulmonary dysfunction 58 macrovascular 58 Prognostic factors 58 prognostic indicators 58 hepatocellular 58 posttransplant 58 Ischemic 58 CDI recurrence 57 Renal Cell Carcinoma RCC 57 virological response 57 ventricular dysfunction 57 postdischarge 57 thrombotic events 57 co morbidities 57 haemodynamic 57 intracerebral haemorrhage 57 attain statistical significance 57 hemodynamic measurements 57 threatening ventricular arrhythmias 57 hypovitaminosis D 57 antibiotic prophylaxis 57 symptomatic hyponatremia 57 artery stenosis 57 plasma triglycerides 57 abdominal adiposity 57 neurocognitive deficits 57 nocturnal hypoglycaemia 57 glomerular filtration 57 hemodilution 57 repeat revascularization 57 multivessel coronary artery 57 metastatic bone 57 % CI #.#-#.# [008] 57 spontaneous preterm delivery 57 systolic hypertension 57 HBeAg negative 57 Heavy menstrual bleeding 57 inhospital 57 abnormal lipid 57 symptomatic NOH 57 salmeterol fluticasone 57 ventricular tachyarrhythmia 57 minimally symptomatic 57 blood Phe levels 57 Chronic ITP 57 Generalized anxiety disorder 57 unplanned readmissions 57 neurologic impairment 57 recurrent VTE 57 fragility fractures 57 VTE prophylaxis 57 thromboembolic 57 colorectal adenoma 57 NSAID induced 57 hepatorenal syndrome 57 serum sodium levels 57 post thrombotic syndrome 57 diabetic kidney 57 ALSFRS R 57 SLNB 57 relapsed MM 57 cerebral oxygenation 57 unstable angina pectoris 57 nonfasting triglyceride levels 57 renal scarring 57 ratio ICER 57 lower extremity amputation 57 aldosterone antagonist 57 pyrexia mucositis sepsis febrile 57 BPS IC 57 ragweed allergic 57 IOP lowering 57 cholestasis 57 Scale EDSS 57 symptomatic intracranial hemorrhage 57 HRQOL 57 urolithiasis 57 Clostridium difficile infections 57 G6PD deficiency 57 hypertension congestive heart 57 CIMZIA TM certolizumab pegol 57 gallstone disease 57 acromegalic patients 57 undiagnosed untreated 57 Critical limb ischemia 57 coinfected patients 57 ischemic cardiomyopathy 57 eculizumab therapy 57 TAXUS VI 57 antiplatelet medication 57 psychosocial variables 57 stroke myocardial infarction 57 antithrombotic therapies 57 hematological parameters 57 bronchial hyperresponsiveness 57 Liver transplantation 57 CMV infection 57 postpartum haemorrhage 57 neurodevelopmental impairment 57 neurological sequelae 57 neurodevelopmental outcome 57 KIF6 carriers 57 liver decompensation 57 neutrophil counts 57 anovulatory infertility 57 SGRQ 57 Secondary endpoints include 57 Comorbid 57 cerebrovascular accidents 57 unfavorable cytogenetics 57 lipid lowering agents 57 Acute myocardial infarction 57 bacterial prostatitis 57 pelvic lymphadenectomy 57 fatal IHD 57 thromboembolism 57 androgen suppression 57 atherosclerotic cardiovascular 57 acute respiratory tract infections 57 postoperative complication 57 Anti retroviral therapy 57 thromboembolic events 57 Thromboembolic 57 decompensated heart failure 57 mechanically ventilated patients 57 hepatic liver 57 nonfatal myocardial infarction MI 57 apo B 57 anemia thrombocytopenia 56 Cardiopulmonary bypass 56 ventricular remodeling 56 noncardiovascular mortality 56 Coronary Artery Bypass Graft 56 atheroma volume 56 metabolic dysregulation 56 clinicopathological features 56 oral anticoagulation 56 ulcer healing 56 ofpatients 56 MADRS score 56 nontraumatic 56 thyrotropin levels 56 micafungin 56 P. falciparum malaria 56 carotid artery narrowing 56 CYP#D# genotype 56 embolic stroke 56 cardio renal 56 Subarachnoid hemorrhage 56 platelet reactivity 56 myeloproliferative neoplasms 56 occlusive disease 56 acutely decompensated congestive heart 56 sacral neuromodulation 56 acute coronary syndromes ACS 56 Myelodysplastic syndromes MDS 56 pathologic fracture 56 serum lipid levels 56 pathologic fractures 56 systemic hypotension 56 serum phosphorous 56 Estrogen deficiency 56 cranial irradiation 56 probiotic supplementation 56 Secondary efficacy endpoints 56 prednisone prednisolone 56 pulmonary exacerbation 56 serum urate levels 56 glucocorticoid therapy 56 mixed hyperlipidemia 56 thetreatment 56 PLX STROKE targeting 56 nonfatal myocardial infarction 56 bicuspid aortic valves 56 ischemic vascular 56 ischemic cardiovascular 56 riociguat 56 nasal polyposis 56 del 5q MDS 56 comorbid psychiatric 56 cerebral perfusion 56 heparin induced thrombocytopenia 56 untreated OSA 56 corticosteroid dose 56 dopaminergic therapy 56 peri procedural 56 chorioamnionitis 56 Oral mucositis 56 chronic rhinosinusitis 56 noncardiac 56 Fibrillex TM 56 proliferative diabetic retinopathy 56 everolimus eluting stents 56 haemorrhagic stroke 56 comorbid depression 56 NNT = 56 bacteriuria 56 obstructive CAD 56 RE LY ® 56 postoperative infection 56 hypercalcaemia 56 myopathy rhabdomyolysis 56 untreated psychosis 56 neutropaenia 56 hepatic cirrhosis 56 atherosclerotic coronary 56 dose atorvastatin 56 myocardial infarction stroke 56 HBV infections 56 stratifying patients 56 malignant neoplasm 56 psoriatic arthritis PsA 56 acid suppressive therapy 56 Heritability 56 mitral regurgitation MR 56 COPD exacerbation 56 hypertension diabetes mellitus 56 nonoperative treatment 56 distal colon cancer 56 femoral neck fracture 56 treat NNT 56 renal insufficiency 56 myocardial infarction ventricular fibrillation 56 shorter telomere length 56 Iron deficiency anemia 56 intrapartum 56 Preterm infants 56 rheumatoid arthritis osteoarthritis ankylosing 56 hyperprolactinemia 56 PSADT 56 non valvular atrial 56 comorbid diagnoses 56 inhospital mortality 56 Combination antiretroviral therapy 56 coronary intervention 56 daytime somnolence 56 carotid IMT 56 antipsychotic prescribing 56 Proteinuria 56 poststroke 56 cardiac repolarization 56 elevated LDH 56 doxorubicin docetaxel 56 iatrogenic 56 malarial anemia 56 internalizing disorders 56 sotalol 56 dose statin therapy 56 ispinesib administered 56 interferon ribavirin 56 atherothrombotic events 56 EDSS score 56 carotid stenosis 56 systemic immunosuppressive drugs 56 CHD CVD 56 severe hypoglycaemia 56 graft patency 56 myocardial fibrosis 56 unmeasured confounding 56 acute myocardial infarction AMI 56 silent ischemia 56 acute postoperative 56 ATACAND 56 antiarrhythmic drug 56 serum triglycerides 56 homocysteine concentrations 56 dosing frequency 56 intravesical therapy 56 CRT ICD 56 PAOD 56 antiphospholipid syndrome 56 See WARNINGS 56 cerebral vasospasm 56 Lung transplantation 56 subthreshold depression 56 Febrile neutropenia 56 ICD implantation 56 β blocker 56 Catheter Associated 56 FFR measurements 56 gastroduodenal 56 interobserver 56 cardiac morbidity 56 thrombocytopenic 56 events ADEs 56 undiagnosed celiac disease 56 SCr 56 peripheral arterial occlusive disease 56 combination antiretroviral therapy 56 TNF antagonist 56 hyperhomocysteinemia 56 nonsevere 56 nonfasting triglycerides 56 Randomized trials 56 adjuvant therapies 56 atherosclerotic vascular disease 56 relapsed AML 55 NOMID 55 Carotid endarterectomy 55 autoantibody levels 55 macrovascular disease 55 suboptimal adherence 55 lupus renal disease 55 hypoxemia 55 Cardio vascular 55 neointimal hyperplasia 55 paclitaxel eluting stents 55 postoperative radiotherapy 55 lipohypertrophy 55 UA NSTEMI 55 fluid overload 55 PCWP 55 Mental disorders 55 Kaplan Meier curve 55 prospective multicenter study 55 parasitemia 55 Adverse effects 55 Comorbidities 55 neutropenic patients 55 Atherothrombosis 55 histological subtype 55 asplenia 55 oropharyngeal 55 reinterventions 55 pharmacokinetic interaction 55 prothrombotic 55 #.#/#.# mmHg [001] 55 FluCAM arm 55 HBeAg seroconversion 55 cerebral oxygen saturation 55 venous reflux 55 overt hepatic encephalopathy 55 carotid plaques 55 tumor necrosis 55 nonpharmacologic 55 Hospitalizations 55 % CI #.#-#.# [007] 55 preserved ejection fraction 55 pharmacological therapies 55 foveal thickness 55 incomplete revascularization 55 Secondary endpoints 55 salivary flow 55 osteoporotic vertebral fractures 55 Psychosocial interventions 55 bypass graft CABG surgery 55 related hematological toxicity 55 breast endometrial 55 carotid artery blockage 55 dose Iluvien 55 hypoglycaemic episodes 55 dysfunctional voiding 55 angina chest 55 neurologic progression 55 adenoma recurrence 55 arterial thrombotic 55 CIMZIA ™ 55 tardive dyskinesia TD 55 atherosclerotic progression 55 C. difficile colitis 55 perinatal outcomes 55 potassium sparing diuretics 55 atrial tachyarrhythmias 55 intermittent hypoxia 55 Ischemic heart 55 CTEPH 55 metabolic parameters 55 HbF 55 cytopenias 55 CVBT #H 55 serum vitamin D 55 haematologic 55 immunocompromised individuals 55 thrombo embolic 55 Secondary endpoints included 55 T1DM 55 postsurgical complications 55 radiographic findings 55 preterm neonates 55 spinal metastases 55 Skin sterol 55 acute myocardial infarction MI 55 pCR 55 CLABSIs 55 serum urate 55 micronutrient supplementation 55 aortic stiffness 55 Severe hypoglycemia 55 restenosis reblockage 55 Stress urinary incontinence 55 parasitaemia 55 severe exacerbations 55 intracerebral hemorrhage ICH 55 fragility fracture 55 uncontrolled asthma 55 Cimzia TM 55 postoperative bleeding 55 initiating antiretroviral therapy 55 pulmonary embolism PE 55 Nesiritide 55 sacral nerve stimulation 55 acute mania 55 chronic renal insufficiency 55 Testosterone deficiency 55 pancreatic insufficiency 55 Pulmonary arterial hypertension 55 chronic hepatitis cirrhosis 55 neuropsychological impairment 55 LAGB 55 sociodemographic characteristics 55 EFFEXOR XR 55 complement inhibitor eculizumab 55 etiologic 55 salmeterol HFA MDI 55 hepatitis B infection 55 microalbuminuria 55 headache nasopharyngitis 55 PLMs 55 VLBW 55 locoregional 55 comorbid disorders 55 ARCOXIA 55 comorbidities 55 renal flares 55 PASI scores 55 prostate carcinogenesis 55 Hp2 2 55 skeletal metastases 55 overt nephropathy 55 debilitating complication 55 psychosocial stressors 55 albumin excretion rate 55 CORE OM 55 fibrotic disease 55 allogeneic HSCT 55 prespecified secondary 55 VAD implantation 55 pneumococcal carriage 55 serum folate concentrations 55 erythropoietic 55 CI #.#-#.# [001] 55 STRIDE PD 55 rehospitalization 55 chronic prostatitis chronic 55 thromboembolic diseases 55 poststroke depression 55 overt hepatic encephalopathy HE 55 hepatic fibrosis 55 ST Segment Elevation 55 angina myocardial infarction 55 6MWD 55 adverse perinatal 55 proliferative retinopathy 55 preoperative intraoperative 55 Natalizumab 55 DEFER 55 Diabetic neuropathy 55 arterial calcification 55 pancreatectomy 55 transfusion transmitted 55 revascularisation 55 Hemodynamic 55 Infusion Reactions Severe 55 diabetes dyslipidemia 55 cardiac dysfunction 55 oral anticoagulant therapy 55 ischemic complications 55 perinatal mortality 55 hypercholesterolaemia 55 acute decompensation 55 acetabular dysplasia 55 C trachomatis 55 indicates cardio circulatory 55 GH deficiency 55 Expanded Disability Status 55 Charlson comorbidity index 55 Diabetes mellitus 55 Secondhand smoke exposure 55 coexisting illnesses 55 pharmacodynamic PD 55 anticholinergic agents 55 primary hyperparathyroidism 55 torsade de pointes 55 Stent thrombosis 55 corticosteroid therapy 55 intraoperative complications 55 pharmacoeconomic 55 Chronic Heart Failure 55 Renal Insufficiency 55 lumbar spine BMD 55 cervicitis 55 chronic rhinosinusitis CRS 55 GI bleeds 55 metabolic abnormalities 55 reactogenicity 55 subgroup analyzes 55 pyridostigmine 55 Hb A1C 55 Primary endpoints 55 Hip fractures 55 APTIVUS r 55 mitral regurgitation 55 nocturnal hypoglycemia 55 beta blocker therapy 55 Clinically significant 55 antiplatelet therapies 55 Osteoporotic fractures 55 definite stent thrombosis 55 HPA axis suppression 55 virologic response 55 coronary artery atherosclerosis 55 retinal thickness 55 rotavirus diarrhea 55 NIH CPSI 55 CMV reactivation 55 Bronchiectasis 55 FFR guided 55 perinatal asphyxia 55 SIADH 55 acute urinary retention 55 fatal myocardial infarction 55 pulmonary toxicity 54 exploratory endpoints 54 Cardiogenic shock 54 nosocomial infection 54 arterial thromboembolic events 54 rFVIIa 54 PROactive study 54 unresectable HCC 54 CHD coronary 54 vitreous floaters 54 gastrointestinal GI motility disorders 54 euthymic patients 54 Intracerebral hemorrhage 54 Coronary artery bypass graft 54 bronchopulmonary dysplasia BPD 54 Tasigna prolongs 54 OSAHS 54 comorbidity 54 Chronic pancreatitis 54 Quetiapine 54 Univariate analysis 54 Aortic stenosis 54 Sleep disordered breathing 54 tirofiban 54 dermatologic reactions 54 left ventricular diastolic 54 osteoporotic compression fractures 54 fibrosis scarring 54 refractory ischemia 54 multiple gestations 54 Logistic regression analysis 54 Pulmonary hypertension 54 uncorrected refractive error 54 HER2 expression 54 MTWA testing 54 Primary IGFD 54 BRCA mutation carriers 54 recurrent atrial fibrillation 54 TMP SMX 54 #OHD 54 BEXXAR Therapeutic Regimen 54 null responder 54 prolonged QT interval 54 vaso occlusive crisis 54 onset diabetes mellitus 54 diabetes mellitus DM 54 Preterm delivery 54 nephrolithiasis 54 dyspnoea 54 perinatal complications 54 MACCE 54 chronic metabolic acidosis 54 herpes zoster shingles 54 revascularization procedures 54 Retreatment 54 ADCS CGIC 54 Asymptomatic 54 lipid elevations 54 Legg Calvé Perthes disease 54 CLBP 54 Postoperative 54 familial clustering 54 Chronic pelvic 54 prospectively defined 54 erythema nodosum 54 cholinergic tone 54 acid suppressive medication 54 hypoglycemic events 54 de novo AML 54 draining enterocutaneous 54 Cardiorespiratory fitness 54 nucleoside naive patients 54 Idiopathic pulmonary fibrosis 54 dyssynchrony 54 limiting generalizability 54 Pneumococcal pneumonia 54 hyperalgesia 54 oxycodone CR 54 PNH patients 54 cardiac contractility 54 viral titers 54 antiplatelet medications 54 Exacerbation 54 Acute Coronary Syndromes ACS 54 clinically localized prostate 54 Ivabradine 54 univariate analyzes 54 polymicrobial 54 intrathoracic 54 glycaemia 54 affective psychosis 54 lymphadenectomy 54 macroalbuminuria 54 severe rotavirus gastroenteritis 54 serum calcium levels 54 Comorbidity 54 arterial thickening 54 cardioembolic stroke 54 portal vein thrombosis 54 inhaled corticosteroid therapy 54 Hematologic toxicity 54 pretest probability 54 angiographic restenosis 54 RSV hospitalizations 54 hour bronchodilation 54 atrioventricular block 54 calcaneal fractures 54 induce orthostatic hypotension 54 distensibility 54 baseline HbA1c 54 adrenalectomy 54 locoregional disease 54 spinal cord compression 54 ATTR CM 54 baseline LDH 54 gastric adenocarcinoma 54 hippocampal atrophy 54 postsurgical 54 ipsilateral stroke 54 tapentadol ER 54 Sleep disturbances 54 antimicrobial prophylaxis 54 associated pneumonia VAP 54 NSAID induced gastrointestinal 54 osteochondroma 54 neonatal respiratory distress 54 erosive GERD 54 MS relapses 54 C difficile infection 54 % CI #.#-#.# [005] 54 acute rheumatic fever 54 landmark ATHENA trial 54 acute coronary syndromes 54 central corneal thickness 54 annualized relapse 54 gastro esophageal reflux 54 Readmissions 54 Overactive bladder 54 Non Alcoholic Steatohepatitis 54 Heavy snorers 54 cSSSI 54 systemic toxicity 54 QoL 54 renal allograft 54 oral prednisolone 54 multivariable analyzes 54 moderate renal impairment 54 fosamprenavir 54 rehospitalizations 54 Cachexia 54 Multivariate logistic regression 54 anginal symptoms 54 inflammatory biomarkers 54 intraventricular hemorrhage 54 metastatic neuroendocrine tumors 54 activated partial thromboplastin 54 atrial fibrillation AFib 54 abnormal vaginal bleeding 54 joint arthroplasty 54 recurrent genital herpes 54 liver transplantations 54 Mucositis 54 receiving VELCADE 54 Statin therapy 54 upper airway obstruction 54 SRBD 54 STRATEGY FOR AN OPEN 54 bony metastases 54 EDSS scores 54 Toxicities 54 Thrombocytopenia 54 warfarin therapy 54 nonalcoholic steatohepatitis NASH 54 Hepatic encephalopathy 54 angiographically 54 prognostic variables 54 QTc intervals 54 virologic suppression 54 Medication adherence 54 Iron Deficiency Anemia 54 NATRECOR R 54 atherosclerotic disease 54 frequent awakenings 54 gastrointestinal bleeds 54 rectovaginal fistulas 54 acute subacute 54 syndrome OSAS 54 recurrent DVT 54 NIHSS score 54 NSAID associated 54 lipid parameters 54 mucosal inflammation 54 cartilage degeneration 54 commonest cause 54 Ebstein anomaly 54 virologic responses 54 recurrent UTI 54 untreated sleep apnea 54 interstitial nephritis 54 hemoptysis 54 tamoxifen Nolvadex ® 54 curability 54 Dysmenorrhea 54 Bronchopulmonary Dysplasia 54 XIENCE V demonstrated 54 pulmonary artery banding 54 NYHA functional class 54 serologically active patients 54 Unintended pregnancies 54 Magnesium deficiency 54 Chronic Bronchitis 54 antiviral efficacy 54 pharmacologic treatments 54 cystic fibrosis chronic pancreatitis 54 glycosylated hemoglobin levels 54 aldosterone antagonists 54 knee osteoarthritis OA 54 liver metastasis 54 cryptogenic stroke 54 intraobserver 54 Chronic Renal Failure 54 C1 INH deficiency 54 Scale EDSS score 54 non metastatic osteosarcoma 54 thrombolytic agents 54 extrapyramidal symptoms EPS 54 endometrial carcinoma 54 nephron sparing surgery 54 serum LDL cholesterol 54 urinary excretion 54 serum lipid 54 metabolic acidosis 54 Target Lesion Revascularization TLR 54 endotoxemia 54 gastric cardia 54 mitral stenosis 54 lowering blood glucose 54 authors conclude 54 preoperative PSA 54 progression TTP 54 CYPHER R Sirolimus eluting 54 esophagogastric 54 Influenza vaccination 54 lenalidomide dexamethasone 54 tissue perfusion 54 Endothelial dysfunction 54 elevated LDL cholesterol 54 lichen planus 54 cytoreduction 54 pyelonephritis 54 immunosuppressive regimen 54 pneumocystis carinii pneumonia 54 abnormal lipids 54 rhinoconjunctivitis 54 OAB symptoms 54 relapsing remitting MS RRMS 54 somatoform disorders 54 dysrhythmias 54 aMCI precursor 54 malaria endemic regions 54 analgesic efficacy 54 multivariable adjusted 54 varicella infection 54 CYPHER Stent 54 decompensated cirrhosis 54 hemodynamic instability 54 left ventricular systolic 54 magnesium intake 54 umol L 54 DES implantation 54 systemic corticosteroid 54 premorbid 54 antiangiogenic agents 54 LVNC 54 multivariate adjustment 54 preoperative diagnosis 54 Peptic ulcer 54 Aggrastat ® tirofiban hydrochloride 54 Socioeconomic status 54 subsyndromal 54 androgen deprivation 54 growth hormone secretion 54 mg BID dose 54 Chemotherapy induced 54 causal pathway 54 hallux valgus 54 HbA 1c levels 54 Kyphon Balloon Kyphoplasty 54 anemia hemoglobin 54 QALY gained